Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What fueled the previous growth in the common warts market?

There has been considerable growth in the market size for common warts in past few years. The market, which stands at $2.13 billion in 2024, is projected to escalate to $2.26 billion in 2025, presenting a compound annual growth rate (CAGR) of 6.2%. The upswing in growth during the historic period is the result of heightened understanding of skin health, an increase in warts cases, a surging need for non-invasive procedures, a rise in the utilization of cryotherapy, and expansion of dermatology clinics.

What will be the common warts market size in the future?

The future years are predicted to witness robust expansion in the market size for common warts, with projections pointing to an increase to $2.83 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. Various factors are contributing to this expected growth within the prediction period, including an aging population, increasing cases of viral infections, widespread uptake of advanced skin treatments, growing preference for tailor-made remedies, and a rise in consumer preference for home-based solutions. Noteworthy trends expected within this period encompass developments in skin disease treatments, growth in healthcare infrastructure, advances in techniques for wart removal, improved knowledge of available treatment choices, and a tendency towards less invasive treatments.

Get your common warts market report here!

https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report

What main drivers are fueling expansion in the common warts market?

The projected growth of the common warts market is expected to be fueled by the rising prevalence of viral infections. Viral infections encompass diseases triggered by the invasion, proliferation and spread of viruses in the body, which often cause cellular damage and disturb immune responses. Factors such as globalization, climate change, urbanization, deforestation, and weakened immunity contribute to the escalating prevalence of these infections. Treatments for common warts typically focus on targeting human papillomavirus (HPV), the pathogen causing wart formation. These treatments aim to control the spread of the virus, ease discomfort, and facilitate healing in patients, while also preventing potential complications like secondary infections or scarring, ultimately improving the patient’s life quality. For example, in 2024, the US-based government agency, Centers for Disease Control and Prevention, reported that the ratio of PCR-verified varicella cases had surged by 62%, moving from 29% to 47% in the last five years. Furthermore, according to the US-based health organization, National Foundation for Infectious Diseases, in January 2023, there are approximately 14 million new instances of HPV infection annually in the United States. Therefore, the escalating prevalence of viral infections is propelling the growth of the common warts market.

What key areas define the segmentation of the global common warts market?

The common warts market covered in this report is segmented –

1) By Treatment Method: Cryotherapy, Laser Treatment, Electrosurgery, Topical Medications

2) By Patient Demographics: Children, Adults, Elderly

3) By Disease Stage: Initial Stage, Moderate Stage, Severe Stage

4) By End User: Hospitals, Dermatology Clinics, Home Care

Subsegments:

1) By Cryotherapy: Liquid Nitrogen Therapy, Carbon Dioxide Therapy

2) By Laser Treatment: Pulsed-Dye Laser Therapy, Carbon Dioxide (CO2) Laser Therapy

3) By Electrosurgery: Curettage And Electrosurgical Removal, High-Frequency Electrosurgical Ablation

4) By Topical Medications: Salicylic Acid-Based Therapy, Immunotherapy-Based Topicals, Retinoid-Based Therapy

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21154&type=smp

Who are the dominant players expanding their reach in the common warts market?

Major companies operating in the common warts market are Major players in the market are AbbVie Inc., GlaxoSmithKline plc, Sun Pharmaceutical Industries Limited, Perrigo Company plc, Holland & Barrett International Limited, Prestige Consumer Healthcare Inc., Maruho Co. Ltd., Novan Inc., X4 Pharmaceuticals Inc., Aclaris Therapeutics Inc., Verrica Pharmaceuticals Inc., RXi Pharmaceuticals Corporation, Scholl’s Wellness Company, Nielsen BioSciences Inc., Cassiopea S.p.A., Orgenesis Inc., KinoPharma Inc., Naturasil, Veradermics Inc., KinoPharma Co. Ltd.

What key trends are currently impacting the common warts market’s development?

Leading businesses in the common warts market are concentrating on developing novel treatments like dermatological therapies. This move is aimed at fulfilling the increasing need for effective and easily accessible solutions, boosting patient outcomes, and broadening their footprint in the dermatology space. Dermatological therapies encompass treatments for various skin conditions such as infections, inflammations, and disorders. For instance, in May 2024, Verrica Pharmaceuticals, a pharmaceutical firm based in the US, entered into a licensing agreement with Torii Pharmaceutical Co. Ltd., a pharmaceutical company headquartered in Japan. The purpose of this alliance is to finance a global Phase 3 clinical trial for YCANTH, a common warts treatment. This partnership aids the advanced-stage development of YCANTH, consequently widening its prospective global penetration. Torii Pharmaceuticals is set to provide financial backing to foster the study. This partnership bolsters the dermatology portfolios of both firms and their presence in the international market.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21154

Which regions are emerging as leaders in the common warts market?

North America was the largest region in the common warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the common warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Anticonvulsants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anticonvulsants-global-market-report

Anti-Vascular Endothelial Growth Factor Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anti-vascular-endothelial-growth-factor-therapeutics-global-market-report

Anti-Inflammatory Therapeutics Global Market Report 2025

https://thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: